Mechanistic and Therapeutic Insights into Ataxic Disorders with Pentanucleotide Expansions
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Pentanucleotide expansion diseases constitute a special class of neurodegeneration. The repeat expansions occur in non-coding regions, have likely arisen from Alu elements, and often result in autosomal dominant or recessive phenotypes with underlying cerebellar neuropathology. When transcribed (potentially bidirectionally), the expanded RNA forms complex secondary and tertiary structures that can give rise to RNA-mediated toxicity, including protein sequestration, pentapeptide synthesis, and mRNA dysregulation. Since several of these diseases have recently been discovered, our understanding of their pathological mechanisms is limited, and their therapeutic interventions underexplored. This review aims to highlight new in vitro and in vivo insights into these incurable diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All these diseases are caused by the same or similar repeat motifs and related RNA-mediated mechanisms (Ishiura and Tsuji, 2020; Loureiro et al., 2022; Zhang and Ashizawa, 2022).”
From Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects (2026) · cites this paper as Zhang and Ashizawa, 2022
In the citing paper
“One of the pathogenic processes that seems to explain the cellular and neurological phenotypes associated with expanded RNA repeats is the abnormal binding and sequestration of RNA-binding proteins (RBPs), which trigger nuclear RNA aggregate formation and RBP loss-of-function”
From Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects (2026) · cites this paper as Zhang and Ashizawa, 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O’Connell, D., Walsh, K. R., Wood, K., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107454 · Cited by 1,801
Scrambler and yotari disrupt the disabled gene and produce a reeler -like phenotype in mice
Sheldon, M., Rice, D. S., D'Arcangelo, G., Yoneshima, H., Nakajima, K., Mikoshiba, K., Howell, B. W., Cooper, J. A., Goldowitz, D., & Curran, T. (1997) · Nature · doi:10.1038/39601 · Cited by 638
Trekking across the Brain: The Journey of Neuronal Migration
Ayala, R., Shu, T., & Tsai, L.-H. (2007) · Cell · doi:10.1016/j.cell.2006.12.021 · Cited by 620 · cited 1×
“The DAB1 gene encodes an adaptor protein in the reelin signaling pathway that is responsible for accurate laminar migration of neurons during brain development [96].”
BackgroundBiallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia
Cortese, A., Simone, R., Sullivan, R., Vandrovcova, J., Tariq, H., Yau, W. Y., Humphrey, J., Jaunmuktane, Z., Sivakumar, P., Polke, J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0372-4 · Cited by 575 · cited 6×
“A causative biallelic AAGGG repeat expansion in intron 2 of the replication factor C1 (RFC1) gene has been identified in tested familial and sporadic CANVAS cases [104,105].”
BackgroundInfluentialGlia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice
Zhou, H., Su, J., Hu, X., Zhou, C., Li, H., Chen, Z., Xiao, Q., Wang, B., Wu, W., Sun, Y., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.024 · Cited by 437
Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
Scoles, D. R., Meera, P., Schneider, M. D., Paul, S., Dansithong, W., Figueroa, K. P., Hung, G., Rigo, F., Bennett, C. F., Otis, T. S., et al. (2017) · Nature · doi:10.1038/nature22044 · Cited by 319
Rafehi, H., Szmulewicz, D. J., Bennett, M. F., Sobreira, N. L. M., Pope, K., Smith, K. R., Gillies, G., Diakumis, P., Dolzhenko, E., Eberle, M. A., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.05.016 · Cited by 262
Nova2 Regulates Neuronal Migration through an RNA Switch in Disabled-1 Signaling
Yano, M., Hayakawa-Yano, Y., Mele, A., & Darnell, R. B. (2010) · Neuron · doi:10.1016/j.neuron.2010.05.007 · Cited by 176
Jafar-nejad, P., Powers, B., Soriano, A., Zhao, H., Norris, D. A., Matson, J., DeBrosse-Serra, B., Watson, J., Narayanan, P., Chun, S. J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1235 · Cited by 128
Lu, H., Sun, J., Liang, W., Chang, Z., Rom, O., Zhao, Y., Zhao, G., Xiong, W., Wang, H., Zhu, T., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044803 · Cited by 98
Research works printed but not linked: 141
- Fondon, 2008, Simple sequence repeats: Genetic modulators of brain function and behavior, Trends Neurosci., 31, 328, 10.1016/j.tins.2008.03.006 · DOI
- Jansen, 2012, Unstable microsatellite repeats facilitate rapid evolution of coding and regulatory sequences, Genome Dyn., 7, 108, 10.1159/000337121 · DOI
- Chintalaphani, 2021, An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics, Acta Neuropathol. Commun., 9, 98, 10.1186/s40478-021-01201-x · DOI · Paper page
- Zhang, 2017, RNA toxicity and foci formation in microsatellite expansion diseases, Curr. Opin. Genet. Dev., 44, 17, 10.1016/j.gde.2017.01.005 · DOI · Paper page
- Peskett, 2018, A Liquid to Solid Phase Transition Underlying Pathological Huntingtin Exon1 Aggregation, Mol. Cell., 70, 588, 10.1016/j.molcel.2018.04.007 · DOI · Paper page
- Rodriguez, 2019, New pathologic mechanisms in nucleotide repeat expansion disorders, Neurobiol. Dis., 130, 104515, 10.1016/j.nbd.2019.104515 · DOI
- Chakraborty, 2020, Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis, Proc. Natl. Acad. Sci. USA, 117, 8154, 10.1073/pnas.1917280117 · DOI
- Gao, 2019, Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription, Elife, 8, e42988, 10.7554/eLife.42988 · DOI · Paper page
- Gerber, 1994, Transcriptional activation modulated by homopolymeric glutamine and proline stretches, Science, 263, 808, 10.1126/science.8303297 · DOI · Paper page
- Massey, 2018, The central role of DNA damage and repair in CAG repeat diseases, Dis. Model. Mech., 11, dmm031930, 10.1242/dmm.031930 · DOI
- Cleary, 2018, Repeat-associated non-ATG (RAN) translation, J. Biol. Chem., 293, 16127, 10.1074/jbc.R118.003237 · DOI
- Manning, 2017, The roles of RNA processing in translating genotype to phenotype, Nat. Rev. Mol. Cell. Biol., 18, 102, 10.1038/nrm.2016.139 · DOI · Paper page
- Zu, 2011, Non-ATG-initiated translation directed by microsatellite expansions, Proc. Natl. Acad. Sci. USA, 108, 260, 10.1073/pnas.1013343108 · DOI · Paper page
- Brouwer, 2009, Microsatellite repeat instability and neurological disease, Bioessays, 31, 71, 10.1002/bies.080122 · DOI · Paper page
- Jain, 2017, RNA phase transitions in repeat expansion disorders, Nature, 546, 243, 10.1038/nature22386 · doi:10.1038/nature22386
- Lin, 2003, SCA10 and ATTCT repeat expansion: Clinical features and molecular aspects, Cytogenet. Genome Res., 100, 184, 10.1159/000072853 · DOI
- Matsuura, 1999, Mapping of the gene for a novel spinocerebellar ataxia with pure cerebellar signs and epilepsy, Ann. Neurol., 45, 407, 10.1002/1531-8249(199903)45:3<407::AID-ANA21>3.0.CO;2-D · doi:10.1002/1531-8249(199903)45:3<407::aid-ana21>3.0.co;2-d
- Matsuura, 2000, Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10, Nat. Genet., 26, 191, 10.1038/79911 · DOI · Paper page
- Zu, 1999, Mapping of a new autosomal dominant spinocerebellar ataxia to chromosome 22, Am. J. Hum. Genet., 64, 594, 10.1086/302247 · DOI
- Bushara, K., Bower, M., Liu, J., McFarland, K.N., Landrian, I., Hutter, D., Teive, H.A., Rasmussen, A., Mulligan, C.J., and Ashizawa, T. (2013). Expansion of the Spinocerebellar ataxia type 10 (SCA10) repeat in a patient with Sioux Native American ancestry. PLoS ONE, 8. · DOI
- Alonso, 2006, Reduced penetrance of intermediate size alleles in spinocerebellar ataxia type 10, Neurology, 66, 1602, 10.1212/01.wnl.0000216266.30177.bb · doi:10.1212/01.wnl.0000216266.30177.bb
- Xia, 2015, Bolivian kindred with combined spinocerebellar ataxia types 2 and 10, Acta Neurol. Scand., 132, 139, 10.1111/ane.12371 · doi:10.1111/ane.12371
- Leonardi, 2014, Spinocerebellar ataxia type 10 in Peru: The missing link in the Amerindian origin of the disease, J. Neurol., 261, 1691, 10.1007/s00415-014-7394-8 · DOI
- Teive, 2004, Clinical phenotype of Brazilian families with spinocerebellar ataxia 10, Neurology, 63, 1509, 10.1212/01.WNL.0000142109.62056.57 · doi:10.1212/01.wnl.0000142109.62056.57
- Bampi, 2019, ATXN10 Microsatellite Distribution in a Peruvian Amerindian Population, Cerebellum, 18, 841, 10.1007/s12311-019-01057-x · doi:10.1007/s12311-019-01057-x
- Naito, H., Takahashi, T., Kamada, M., Morino, H., Yoshino, H., Hattori, N., Maruyama, H., Kawakami, H., and Matsumoto, M. (2017). First report of a Japanese family with spinocerebellar ataxia type 10: The second report from Asia after a report from China. PLoS ONE, 12. · DOI
- Wang, 2015, Spinocerebellar ataxia type 10 in Chinese Han, Neurol. Genet., 1, e26, 10.1212/NXG.0000000000000026 · doi:10.1212/nxg.0000000000000026
- Almeida, T., Alonso, I., Martins, S., Ramos, E.M., Azevedo, L., Ohno, K., Amorim, A., Saraiva-Pereira, M.L., Jardim, L.B., and Matsuura, T. (2009). Ancestral origin of the ATTCT repeat expansion in spinocerebellar ataxia type 10 (SCA10). PLoS ONE, 4. · DOI
- Matsuura, 2006, Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: Repeat purity as a disease modifier?, Am. J. Hum. Genet., 78, 125, 10.1086/498654 · DOI
- McFarland, K.N., Liu, J., Landrian, I., Godiska, R., Shanker, S., Yu, F., Farmerie, W.G., and Ashizawa, T. (2015). SMRT Sequencing of Long Tandem Nucleotide Repeats in SCA10 Reveals Unique Insight of Repeat Expansion Structure. PLoS ONE, 10. · DOI
- McFarland, 2014, Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures, Neurogenetics, 15, 59, 10.1007/s10048-013-0385-6 · doi:10.1007/s10048-013-0385-6
- Wright, 2020, Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range, Genet. Med., 22, 2108, 10.1038/s41436-020-0917-z · DOI
- Pesovic, 2018, Repeat Interruptions Modify Age at Onset in Myotonic Dystrophy Type 1 by Stabilizing DMPK Expansions in Somatic Cells, Front. Genet., 9, 601, 10.3389/fgene.2018.00601 · DOI
- Wright, 2020, Interrupting sequence variants and age of onset in Huntington’s disease: Clinical implications and emerging therapies, Lancet Neurol., 19, 930, 10.1016/S1474-4422(20)30343-4 · DOI
- Rasmussen, 2001, Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10, Ann. Neurol., 50, 234, 10.1002/ana.1081 · DOI
- Diaz, 2019, Extensive cerebellar and thalamic degeneration in spinocerebellar ataxia type 10, Parkinsonism Relat. Disord., 66, 182, 10.1016/j.parkreldis.2019.08.011 · doi:10.1016/j.parkreldis.2019.08.011
- Xia, 2013, Purkinje cell loss is the major brain pathology of spinocerebellar ataxia type 10, J. Neurol. Neurosurg. Psychiatry, 84, 1409, 10.1136/jnnp-2013-305080 · DOI
- Grewal, 2002, Clinical features and ATTCT repeat expansion in spinocerebellar ataxia type 10, Arch. Neurol., 59, 1285, 10.1001/archneur.59.8.1285 · DOI
- Ashizawa, 2001, Spinocerebellar ataxia type 10 (SCA10): A disease caused by a novel pentanucleotide repeat expansion, Rinsho Shinkeigaku, 41, 1120
- Kurosaki, 2009, Alu-mediated acquisition of unstable ATTCT pentanucleotide repeats in the human ATXN10 gene, Mol. Biol. Evol., 26, 2573, 10.1093/molbev/msp172 · DOI
- Potaman, 2003, Unpaired structures in SCA10 (ATTCT)n.(AGAAT)n repeats, J. Mol. Biol., 326, 1095, 10.1016/S0022-2836(03)00037-8 · DOI
- Handa, 2005, The AUUCU repeats responsible for spinocerebellar ataxia type 10 form unusual RNA hairpins, J. Biol. Chem., 280, 29340, 10.1074/jbc.M503495200 · DOI
- Guo, 2020, Minidumbbell structures formed by ATTCT pentanucleotide repeats in spinocerebellar ataxia type 10, Nucleic Acids Res., 48, 7557
- Wojciechowska, 2011, Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference, Nucleic Acids Res., 39, 3852, 10.1093/nar/gkq1323 · DOI · Paper page
- Napierala, 1997, CUG repeats present in myotonin kinase RNA form metastable “slippery” hairpins, J. Biol. Chem., 272, 31079, 10.1074/jbc.272.49.31079 · DOI · Paper page
- Reddy, 2013, The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures, J. Biol. Chem., 288, 9860, 10.1074/jbc.C113.452532 · DOI · Paper page
- Park, 2015, Crystallographic and Computational Analyses of AUUCU Repeating RNA That Causes Spinocerebellar Ataxia Type 10 (SCA10), Biochemistry, 54, 3851, 10.1021/acs.biochem.5b00551 · doi:10.1021/acs.biochem.5b00551
- Komar, 2005, Internal ribosome entry sites in cellular mRNAs: Mystery of their existence, J. Biol. Chem., 280, 23425, 10.1074/jbc.R400041200 · DOI · Paper page
- Komar, 2011, Cellular IRES-mediated translation: The war of ITAFs in pathophysiological states, Cell Cycle, 10, 229, 10.4161/cc.10.2.14472 · DOI · Paper page
- Green, 2017, RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response, Nat. Commun., 8, 2005, 10.1038/s41467-017-02200-0 · DOI · Paper page
- Wakamiya, 2006, The role of ataxin 10 in the pathogenesis of spinocerebellar ataxia type 10, Neurology, 67, 607, 10.1212/01.wnl.0000231140.26253.eb · DOI
- Sznajder, 2018, Intron retention induced by microsatellite expansions as a disease biomarker, Proc. Natl. Acad. Sci. USA, 115, 4234, 10.1073/pnas.1716617115 · DOI · Paper page
- Keren, 2010, Evidence against haploinsuffiency of human ataxin 10 as a cause of spinocerebellar ataxia type 10, Neurogenet., 11, 273, 10.1007/s10048-009-0227-8 · doi:10.1007/s10048-009-0227-8
- White, M.C., Gao, R., Xu, W., Mandal, S.M., Lim, J.G., Hazra, T.K., Wakamiya, M., Edwards, S.F., Raskin, S., and Teive, H.A. (2010). Inactivation of hnRNP K by expanded intronic AUUCU repeat induces apoptosis via translocation of PKCdelta to mitochondria in spinocerebellar ataxia 10. PLoS Genet., 6. · DOI · Paper page
- McFarland, 2012, Transgenic models of spinocerebellar ataxia type 10: Modeling a repeat expansion disorder, Genes, 3, 481, 10.3390/genes3030481 · DOI
- White, 2012, Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure: A toxic RNA gain-of-function model, J. Neurosci. Res., 90, 706, 10.1002/jnr.22786 · doi:10.1002/jnr.22786
- Bomsztyk, 2004, hnRNP K: One protein multiple processes, Bioessays, 26, 629, 10.1002/bies.20048 · DOI · Paper page
- Auweter, 2006, Sequence-specific binding of single-stranded RNA: Is there a code for recognition?, Nucleic Acids Res., 34, 4943, 10.1093/nar/gkl620 · DOI · Paper page
- Gallardo, 2016, Aberrant hnRNP K expression: All roads lead to cancer, Cell Cycle, 15, 1552, 10.1080/15384101.2016.1164372 · DOI
- Schultz, 2020, Cancer frequency in patients with spinocerebellar ataxia type 10, Parkinsonism Relat. Disord., 76, 1, 10.1016/j.parkreldis.2020.05.032 · doi:10.1016/j.parkreldis.2020.05.032
- Cherng, 2011, Expansions, contractions, and fragility of the spinocerebellar ataxia type 10 pentanucleotide repeat in yeast, Proc. Natl. Acad. Sci. USA, 108, 2843, 10.1073/pnas.1009409108 · DOI · Paper page
- Liu, 2007, Unstable spinocerebellar ataxia type 10 (ATTCT*(AGAAT) repeats are associated with aberrant replication at the ATX10 locus and replication origin-dependent expansion at an ectopic site in human cells, Mol. Cell. Biol., 27, 7828, 10.1128/MCB.01276-07 · DOI
- Hashem, V., Tiwari, A., Bewick, B., Teive, H.A.G., Moscovich, M., Schuele, B., Bushara, K., Bower, M., Rasmussen, A., and Tsai, Y.C. (2020). Pulse-Field capillary electrophoresis of repeat-primed PCR amplicons for analysis of large repeats in Spinocerebellar Ataxia Type 10. PLoS ONE, 15. · doi:10.1371/journal.pone.0231746
- Yang, 2016, Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10, Nat. Commun., 7, 11647, 10.1038/ncomms11647 · DOI
- Rzuczek, 2017, Precise small-molecule recognition of a toxic CUG RNA repeat expansion, Nat. Chem. Biol., 13, 188, 10.1038/nchembio.2251 · DOI · Paper page
- Lee, 2007, 16q-linked autosomal dominant cerebellar ataxia in a Korean family, Eur. J. Neurol., 14, e16, 10.1111/j.1468-1331.2007.01818.x · doi:10.1111/j.1468-1331.2007.01818.x
- Lee, 2012, SCA31 is rare in the Chinese population on Taiwan, Neurobiol. Aging, 33, 426.e23, 10.1016/j.neurobiolaging.2010.10.012 · doi:10.1016/j.neurobiolaging.2010.10.012
- Ouyang, 2012, Spinocerebellar ataxia type 31 exists in northeast China, J. Neurol. Sci., 316, 164, 10.1016/j.jns.2012.02.005 · doi:10.1016/j.jns.2012.02.005
- Yang, 2018, Analysis of spinocerebellar ataxia type 31 related mutations among patients from mainland China, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 35, 309
- Ishikawa, 2011, Pentanucleotide repeats at the spinocerebellar ataxia type 31 (SCA31) locus in Caucasians, Neurol. Aging, 77, 1853
- Pedroso, 2015, When should we test patients with familial ataxias for SCA31? A misdiagnosed condition outside Japan?, J. Neurol. Sci., 355, 206, 10.1016/j.jns.2015.05.016 · doi:10.1016/j.jns.2015.05.016
- Nakamura, 2017, Natural History of Spinocerebellar Ataxia Type 31: A 4-Year Prospective Study, Cerebellum, 16, 518, 10.1007/s12311-016-0833-6 · DOI
- Owada, 2005, A clinical, genetic, and neuropathologic study in a family with 16q-linked ADCA type III, Neurology, 65, 629, 10.1212/01.wnl.0000173065.75680.e2 · DOI
- Itaya, 2018, Spinocerebellar Ataxia Type 31 with Blepharospasm, Intern. Med., 57, 1651, 10.2169/internalmedicine.0068-17 · doi:10.2169/internalmedicine.0068-17
- Norioka, 2021, Midbrain atrophy related to parkinsonism in a non-coding repeat expansion disorder: Five cases of spinocerebellar ataxia type 31 with nigrostriatal dopaminergic dysfunction, Cerebellum Ataxias, 8, 11, 10.1186/s40673-021-00134-4 · DOI
- Ishikawa, 2010, The chromosome 16q-linked autosomal dominant cerebellar ataxia (16q-ADCA): A newly identified degenerative ataxia in Japan showing peculiar morphological changes of the Purkinje cell: The 50th Anniversary of Japanese Society of Neuropathology, Neuropathology, 30, 490, 10.1111/j.1440-1789.2010.01142.x · doi:10.1111/j.1440-1789.2010.01142.x
- Niimi, 2013, Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis, Neuropathology, 33, 600, 10.1111/neup.12032 · DOI
- Yoshida, 2014, Distinctive features of degenerating Purkinje cells in spinocerebellar ataxia type 31, Neuropathology, 34, 261, 10.1111/neup.12090 · doi:10.1111/neup.12090
- Sato, 2009, Spinocerebellar ataxia type 31 is associated with “inserted” penta-nucleotide repeats containing (TGGAA)n, Am. J. Hum. Genet., 85, 544, 10.1016/j.ajhg.2009.09.019 · DOI · Paper page
- Ishiguro, 2017, Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31, Neuron, 94, 108, 10.1016/j.neuron.2017.02.046 · DOI · Paper page
- Valgardsdottir, 2008, Transcription of Satellite III non-coding RNAs is a general stress response in human cells, Nucleic Acids Res., 36, 423, 10.1093/nar/gkm1056 · DOI · Paper page
- Valgardsdottir, 2005, Structural and functional characterization of noncoding repetitive RNAs transcribed in stressed human cells, Mol. Biol. Cell., 16, 2597, 10.1091/mbc.e04-12-1078 · DOI · Paper page
- Goenka, 2016, Human satellite-III non-coding RNAs modulate heat-shock-induced transcriptional repression, J. Cell. Sci., 129, 3541, 10.1242/jcs.189803 · DOI
- Chiodi, 2004, RNA recognition motif 2 directs the recruitment of SF2/ASF to nuclear stress bodies, Nucleic Acids Res., 32, 4127, 10.1093/nar/gkh759 · DOI
- Metz, 2004, A key role for stress-induced satellite III transcripts in the relocalization of splicing factors into nuclear stress granules, J. Cell. Sci., 117, 4551, 10.1242/jcs.01329 · DOI
- Ishiguro, 2021, Insight Into Spinocerebellar Ataxia Type 31 (SCA31) From Drosophila Model, Front. Neurosci., 15, 648133, 10.3389/fnins.2021.648133 · DOI
- McLoughlin, 2020, Pathogenesis of SCA3 and implications for other polyglutamine diseases, Neurobiol. Dis., 134, 104635, 10.1016/j.nbd.2019.104635 · DOI · Paper page
- Kumar, 2014, Transcriptional dysregulation in Huntington’s disease: A failure of adaptive transcriptional homeostasis, Drug Discov. Today, 19, 956, 10.1016/j.drudis.2014.03.016 · DOI · Paper page
- Huang, Y.C., Lin, K.F., He, R.Y., Tu, P.H., Koubek, J., Hsu, Y.C., and Huang, J.J. (2013). Inhibition of TDP-43 aggregation by nucleic acid binding. PLoS ONE, 8. · DOI · Paper page
- Mann, 2019, RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43, Neuron, 102, 321, 10.1016/j.neuron.2019.01.048 · DOI · Paper page
- Shibata, 2021, Small molecule targeting r(UGGAA)n disrupts RNA foci and alleviates disease phenotype in Drosophila model, Nat. Commun., 12, 236, 10.1038/s41467-020-20487-4 · DOI
- Seixas, 2017, A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar Ataxia, Am. J. Hum. Genet., 101, 87, 10.1016/j.ajhg.2017.06.007 · DOI · Paper page
- Stevanin, 2013, New subtype of spinocerebellar ataxia with altered vertical eye movements mapping to chromosome 1p32, JAMA Neurol., 70, 764, 10.1001/jamaneurol.2013.2311 · DOI
- Rabano, 2018, Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37, Brain, 141, 1981, 10.1093/brain/awy137 · DOI · Paper page
- Goldowitz, 1997, Cerebellar disorganization characteristic of reeler in scrambler mutant mice despite presence of reelin, J. Neurosci., 17, 8767, 10.1523/JNEUROSCI.17-22-08767.1997 · DOI · Paper page
- Sweet, 1996, Scrambler, a new neurological mutation of the mouse with abnormalities of neuronal migration, Mamm. Genome, 7, 798, 10.1007/s003359900240 · DOI
- Lee, 2003, XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response, Mol. Cell. Biol., 23, 7448, 10.1128/MCB.23.21.7448-7459.2003 · DOI · Paper page
- Cortese, 2020, Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion, Brain, 143, 480, 10.1093/brain/awz418 · DOI · Paper page
- Szmulewicz, 2011, Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS): A review of the clinical features and video-oculographic diagnosis, Ann. N. Y. Acad. Sci., 1233, 139, 10.1111/j.1749-6632.2011.06158.x · DOI · Paper page
- Szmulewicz, 2014, Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS, Neurology, 82, 1410, 10.1212/WNL.0000000000000352 · DOI
- Sullivan, 2021, Cerebellar ataxia, neuropathy, vestibular areflexia syndrome: Genetic and clinical insights, Curr. Opin. Neurol., 34, 556, 10.1097/WCO.0000000000000961 · DOI
- Pelosi, 2018, Peripheral nerves are pathologically small in cerebellar ataxia neuropathy vestibular areflexia syndrome: A controlled ultrasound study, Eur. J. Neurol., 25, 659, 10.1111/ene.13563 · DOI
- Reyes-Leiva, D., Aldecoa, I., Gelpi, E., and Rojas-Garcia, R. (2022). Motor neuron involvement expands the neuropathological phenotype of late-onset ataxia in RFC1 mutation (CANVAS). Brain Pathol., e13051. · DOI
- Huin, V., Coarelli, G., Guemy, C., Boluda, S., Debs, R., Mochel, F., Stojkovic, T., Grabli, D., Maisonobe, T., and Gaymard, B. (2021). Motor neuron pathology in CANVAS due to RFC1 expansions. Brain, awab449. · DOI
- Akcimen, 2019, Investigation of the RFC1 Repeat Expansion in a Canadian and a Brazilian Ataxia Cohort: Identification of Novel Conformations, Front. Genet., 10, 1219, 10.3389/fgene.2019.01219 · DOI
- Scriba, 2020, A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS families, Brain, 143, 2904, 10.1093/brain/awaa263 · DOI
- Tsuchiya, 2020, RFC1 repeat expansion in Japanese patients with late-onset cerebellar ataxia, J. Hum. Genet., 65, 1143, 10.1038/s10038-020-0807-x · DOI
- Beecroft, 2020, A Maori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele, Brain, 143, 2673, 10.1093/brain/awaa203 · DOI
- Lek, 2016, Analysis of protein-coding genetic variation in 60,706 humans, Nature, 536, 285, 10.1038/nature19057 · DOI · Paper page
- Loureiro, J.R., Castro, A.F., Figueiredo, A.S., and Silveira, I. (2022). Molecular Mechanisms in Pentanucleotide Repeat Diseases. Cells, 11. · DOI · Paper page
- Hesselberth, 2013, Lives that introns lead after splicing, Wires RNA, 4, 677, 10.1002/wrna.1187 · DOI
- Hautbergue, 2017, SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits, Nat. Commun., 8, 16063, 10.1038/ncomms16063 · DOI · Paper page
- Campuzano, 1997, Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes, Hum. Mol. Genet., 6, 1771, 10.1093/hmg/6.11.1771 · DOI · Paper page
- Campuzano, 1996, Friedreich’s ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion, Science, 271, 1423, 10.1126/science.271.5254.1423 · DOI · Paper page
- Garcia, J.C., and Bustos, R.H. (2018). The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives. Brain Sci., 8. · DOI
- Wang, 2018, Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9, Mol. Ther., 26, 2617, 10.1016/j.ymthe.2018.09.003 · DOI
- Monteys, 2017, CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo, Mol. Ther., 25, 12, 10.1016/j.ymthe.2016.11.010 · DOI · Paper page
- Dastidar, 2018, Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells, Nucleic Acids Res., 46, 8275, 10.1093/nar/gky548 · DOI
- Pinto, 2017, Impeding Transcription of Expanded Microsatellite Repeats by Deactivated Cas9, Mol. Cell., 68, 479, 10.1016/j.molcel.2017.09.033 · DOI
- Batra, 2017, Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9, Cell, 170, 899, 10.1016/j.cell.2017.07.010 · DOI · Paper page
- Zhang, 2020, A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1, Front. Genet., 11, 594576, 10.3389/fgene.2020.594576 · DOI
- Andre, 2017, CRISPR/Cas9-Induced (CTGCAG)n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing, Mol. Ther., 25, 24, 10.1016/j.ymthe.2016.10.014 · DOI
- Wheeler, 2009, Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA, Science, 325, 336, 10.1126/science.1173110 · DOI · Paper page
- Manning, 2017, BNA(NC) Gapmers Revert Splicing and Reduce RNA Foci with Low Toxicity in Myotonic Dystrophy Cells, ACS Chem. Biol., 12, 2503, 10.1021/acschembio.7b00416 · DOI
- Wheeler, 2012, Targeting nuclear RNA for in vivo correction of myotonic dystrophy, Nature, 488, 111, 10.1038/nature11362 · DOI · Paper page
- Jauvin, 2017, Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice, Mol. Ther. Nucleic Acids, 7, 465, 10.1016/j.omtn.2017.05.007 · DOI
- McLoughlin, 2018, Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice, Ann. Neurol., 84, 64, 10.1002/ana.25264 · DOI · Paper page
- Moore, 2019, Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line, Stem Cell Res., 39, 101504, 10.1016/j.scr.2019.101504 · DOI
- Zhang, 2021, DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases, Neurotherapeutics, 18, 1710, 10.1007/s13311-021-01075-w · DOI
- Cinesi, 2016, Contracting CAG/CTG repeats using the CRISPR-Cas9 nickase, Nat. Commun., 7, 13272, 10.1038/ncomms13272 · DOI
- Ouellet, 2017, Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich ataxia, Gene. Ther., 24, 265, 10.1038/gt.2016.89 · DOI
- Ikeda, 2020, Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach, Mol. Ther. Methods Clin. Dev., 18, 131, 10.1016/j.omtm.2020.05.024 · DOI
- Mosbach, V., Viterbo, D., Descorps-Declere, S., Poggi, L., Vaysse-Zinkhofer, W., and Richard, G.F. (2020). Resection and repair of a Cas9 double-strand break at CTG trinucleotide repeats induces local and extensive chromosomal deletions. PLoS. Genet., 16. · DOI
- Rong, 2020, Trinucleotide Repeat-Targeting dCas9 as a Therapeutic Strategy for Fuchs’ Endothelial Corneal Dystrophy, Transl. Vis. Sci. Technol., 9, 47, 10.1167/tvst.9.9.47 · doi:10.1167/tvst.9.9.47
- Burstein, 2017, New CRISPR-Cas systems from uncultivated microbes, Nature, 542, 237, 10.1038/nature21059 · DOI · Paper page
- Harrington, 2018, Programmed DNA destruction by miniature CRISPR-Cas14 enzymes, Science, 362, 839, 10.1126/science.aav4294 · DOI · Paper page
- Pausch, 2020, CRISPR-CasPhi from huge phages is a hypercompact genome editor, Science, 369, 333, 10.1126/science.abb1400 · DOI · Paper page
- Wang, 2019, The CRISPR-Cas13a Gene-Editing System Induces Collateral Cleavage of RNA in Glioma Cells, Adv. Sci., 6, 1901299, 10.1002/advs.201901299 · DOI · Paper page
- Zhao, 2018, A CRISPR-Cas13a system for efficient and specific therapeutic targeting of mutant KRAS for pancreatic cancer treatment, Cancer Lett., 431, 171, 10.1016/j.canlet.2018.05.042 · DOI · Paper page
- Abbott, 2020, Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza, Cell, 181, 865, 10.1016/j.cell.2020.04.020 · DOI · Paper page
- Zhang, 2022, DNAzyme as a rising gene-silencing agent in theranostic settings, Neural Regen. Res., 17, 1989, 10.4103/1673-5374.335157 · DOI
Cited by
Castro, A. F., Figueiredo, A. S., Loureiro, J. R., Azevedo, M. M., Sampaio, P., Valentim, A. M., Bessa, J., & Silveira, I. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052636 · Cited by 3
Metadata
- Authors
- Zhang, N., & Ashizawa, T.
- Affiliations
- Neuroscience Research Program, Department of Neurology, Houston Methodist Research Institute, Weil Cornell Medical College, Houston, TX 77030, USA
- ORCID
- Zhang, Nan
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-05-06
- Volume
- 11
- Issue
- 9
- Pages
- 1567
- ISSN
- 2073-4409
- Cited by
- 14
- References
- 10
- Language
- en
- Funders
- Forster Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.